Sun Pharma Q1 Update by Epic Research

Net Profit At Rs 1,391 Crore Versus Loss Of Rs 1,276 Crore (YoY)



Revenue At Rs 3,935.6 Crore Versus Rs 3,502.7 Crore (YoY)



EBITDA At Rs 1,732.6 Crore Versus Rs 1,551.2 Crore (YoY)



Operating Margin At 44 percent Versus 44.3 percent (YoY)



India branded generic sales up 17 percent at Rs 992 Crore (YoY)



US finished dosage sales up 7 percent at USD 389 million (YoY)



International formulation sales outside us up 2 percent at USD 82 million (YoY)



Sun Pharma says total international revenues accounted for more than 75 percent of total revenue in Q1



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips